A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers
NCT01740609 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2014-06-19
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of single escalating doses PF-06342674.
Conditions
- Healthy
Interventions
- DRUG
-
Placebo
- BIOLOGICAL
-
PF-06342674 Dose A
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose B
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose C
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose D
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose E
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose F
Single IV Dose
- BIOLOGICAL
-
PF-06342674 Dose G
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose H
Single IV Dose
- BIOLOGICAL
-
PF-06342674 Dose I
Single SC Dose
- BIOLOGICAL
-
PF-06342674 Dose J
Single IV Dose
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-11-30
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers
NCT01897142 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers
NCT00797342 ·Status: COMPLETED ·Phase: PHASE1
-
Single Ascending Dose Study of Intravenous Infusion of PF 07304814 in Healthy Adult Participants
NCT04627532 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Of PF-06291874 In Healthy Adult Subjects
NCT01499017 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults
NCT06659250 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects
NCT03309241 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers
NCT02066909 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
NCT03351751 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Single-Dose Escalation Study of PF-04308515 in Healthy Volunteers
NCT00990015 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers
NCT01161069 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
NCT01626976 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human Study Of Increasing Oral Doses Of PF-04634817
NCT01098877 ·Status: COMPLETED ·Phase: PHASE1
-
A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants
NCT05434091 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
NCT01691274 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated
NCT01165723 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
NCT01934738 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects
NCT02485769 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults
NCT06821750 ·Status: TERMINATED ·Phase: PHASE1
-
A Study To Access The Safety And Tolerability Of RN316 (PF-04950615) When Administered To Healthy Adult Subjects
NCT00991159 ·Status: COMPLETED ·Phase: PHASE1
-
First In Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 Administered Intravenously To Healthy Adult Volunteers
NCT01011296 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects
NCT01616277 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate HT-6184 in Healthy Subjects
NCT05447546 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Escalation Study of PF-06741086 In Healthy Subjects
NCT02531815 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Trial to Investigate the Safety and Tolerability of PF-06412562
NCT01914796 ·Status: COMPLETED ·Phase: PHASE1